These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28033168)

  • 1. Is cardiovascular risk a concern when prescribing azithromycin?
    Sutton SS
    JAAPA; 2017 Jan; 30(1):11-13. PubMed ID: 28033168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azithromycin and the risk of cardiovascular complications.
    Maisch NM; Kochupurackal JG; Sin J
    J Pharm Pract; 2014 Oct; 27(5):496-500. PubMed ID: 25374989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azithromycin-induced proarrhythmia and cardiovascular death.
    Howard PA
    Ann Pharmacother; 2013 Nov; 47(11):1547-51. PubMed ID: 24285766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case-based approach to evaluating azithromycin use and cardiovascular risks.
    Wong E; Nguyen TV
    Consult Pharm; 2014 Jan; 29(1):47-52. PubMed ID: 24413014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azithromycin-induced torsade de pointes.
    Huang BH; Wu CH; Hsia CP; Yin Chen C
    Pacing Clin Electrophysiol; 2007 Dec; 30(12):1579-82. PubMed ID: 18070319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azithromycin for the Prevention of COPD Exacerbations: The Good, Bad, and Ugly.
    Taylor SP; Sellers E; Taylor BT
    Am J Med; 2015 Dec; 128(12):1362.e1-6. PubMed ID: 26291905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azithromycin as a cause of QT-interval prolongation and torsade de pointes in the absence of other known precipitating factors.
    Kezerashvili A; Khattak H; Barsky A; Nazari R; Fisher JD
    J Interv Card Electrophysiol; 2007 Apr; 18(3):243-6. PubMed ID: 17546486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risks of cardiac arrhythmia and mortality among patients using new-generation macrolides, fluoroquinolones, and β-lactam/β-lactamase inhibitors: a Taiwanese nationwide study.
    Chou HW; Wang JL; Chang CH; Lai CL; Lai MS; Chan KA
    Clin Infect Dis; 2015 Feb; 60(4):566-77. PubMed ID: 25409476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Appraisal of the cardiovascular risks of azithromycin: an observational analysis.
    Sutton SS; Hyche S; Magagnoli J; Hardin JW
    J Comp Eff Res; 2017 Sep; 6(6):509-517. PubMed ID: 28960092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Torsades de pointes induced by the concomitant use of ivabradine and azithromycin: an unexpected dangerous interaction.
    Cocco G; Jerie P
    Cardiovasc Toxicol; 2015 Jan; 15(1):104-6. PubMed ID: 25158669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azithromycin is not associated with QT prolongation in hospitalized patients with community-acquired pneumonia.
    Goldstein LH; Gabin A; Fawaz A; Freedberg NA; Schwartz N; Elias M; Saliba W
    Pharmacoepidemiol Drug Saf; 2015 Oct; 24(10):1042-8. PubMed ID: 26238864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of baseline corrected QT interval and azithromycin prescriptions in an academic medical center.
    Lee RA; Guyton A; Kunz D; Cutter GR; Hoesley CJ
    J Hosp Med; 2016 Jan; 11(1):15-20. PubMed ID: 26287278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of azithromycin and death from cardiovascular causes.
    Svanström H; Pasternak B; Hviid A
    N Engl J Med; 2013 May; 368(18):1704-12. PubMed ID: 23635050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azithromycin and the risk of cardiovascular death.
    Ray WA; Murray KT; Hall K; Arbogast PG; Stein CM
    N Engl J Med; 2012 May; 366(20):1881-90. PubMed ID: 22591294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In brief: Safety of azithromycin.
    Med Lett Drugs Ther; 2012 Jun; 54(1392):45. PubMed ID: 22683925
    [No Abstract]   [Full Text] [Related]  

  • 16. Heart health and antibiotics safety: Z-Pak update.
    Harv Health Lett; 2012 Aug; 37(10):3. PubMed ID: 22991727
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of Cardiac Events Associated With Azithromycin vs Amoxicillin.
    Patel H; Calip GS; DiDomenico RJ; Schumock GT; Suda KJ; Lee TA
    JAMA Netw Open; 2020 Sep; 3(9):e2016864. PubMed ID: 32930780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azithromycin: cardiovascular deaths.
    Prescrire Int; 2013 Jan; 22(134):17. PubMed ID: 23383407
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiac risks associated with antibiotics: azithromycin and levofloxacin.
    Lu ZK; Yuan J; Li M; Sutton SS; Rao GA; Jacob S; Bennett CL
    Expert Opin Drug Saf; 2015 Feb; 14(2):295-303. PubMed ID: 25494485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrolides use and the risk of sudden cardiac death.
    Li X; Wang M; Liu G; Zhou L; Wang Z; Li C
    Expert Rev Anti Infect Ther; 2016 Jun; 14(6):535-7. PubMed ID: 27086751
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.